(177)Lu-3PRGD2

N/A

Report date: 2025/11/20 16:04:47

Base Information

Drug Name(177)Lu-3PRGD2

Drug Alias Name177-Lu-3-PRGD-2177Lu-3PRGD2(177)Lu-3PRGD2

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionIonising radiation emittersIntegrin alpha-V/beta-3 antagonists

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesPeking University

China Registration ClassN/A

Develop Information

Active CompaniesPeking University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A